Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Xylem's Third Quarter 2024 Earnings presented a mixed financial picture marked by strong profit margins and operational discipline but moderated revenue growth.</li><li>CEO Matthew Pine highlighted robust earnings and record EBITDA margins achieved during the quarter due to disciplined execution across the business and efficient integration of Evoqua, which is now ahead of schedule in cost synergies.</li><li>Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.</li></ul>

Xylem's Third Quarter 2024 Earnings presented a mixed financial picture marked by strong profit margins and operational discipline but moderated revenue growth.CEO Matthew Pine highlighted robust earnings and record EBITDA margins achieved during the quarter due to disciplined execution across the business and efficient integration of Evoqua, which is now ahead of schedule in cost synergies.Baptista Research looks to evaluate the different factors that could influence the company's price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Xylem Inc.: How Its Recent Operational Excellence & Synergy Capture From Evoqua Integration Driving our Optimism! - Major Drivers

<ul><li>Xylem's performance in the second quarter of 2024 has exceeded expectations across several key metrics.</li><li>The company has demonstrated strong financial and operational results, driven by strategic initiatives and market expansion efforts, particularly with the integration of Evoqua.</li><li>This synergy has not only strengthened their market position but also brought about cost efficiencies.</li></ul>

Xylem's performance in the second quarter of 2024 has exceeded expectations across several key metrics.The company has demonstrated strong financial and operational results, driven by strategic initiatives and market expansion efforts, particularly with the integration of Evoqua.This synergy has not only strengthened their market position but also brought about cost efficiencies.

Xylem Inc.: Strategic Focus On Emerging Markets & Diverse Portfolio Driving Our Bullish Thesis! - Major Drivers

<ul><li>On the optimistic front, Xylem reported a formidable first-quarter, outperforming expectations across revenue, margin, and earnings per share.</li><li>Xylem's team led high single-digit organic revenue growth attributed to evenly distributed volume and price.</li><li>Furthermore, they achieved an almost 300 basis points expansion in adjusted EBITDA margin, driving EPS growth of 14%.</li></ul>

On the optimistic front, Xylem reported a formidable first-quarter, outperforming expectations across revenue, margin, and earnings per share.Xylem's team led high single-digit organic revenue growth attributed to evenly distributed volume and price.Furthermore, they achieved an almost 300 basis points expansion in adjusted EBITDA margin, driving EPS growth of 14%.

Xylem Inc.: Maximizing Value Through Integration! - Major Drivers

<ul><li>Xylem Inc.</li><li>delivered a strong financial performance for its fourth quarter, exceeding expectations in both revenue and earnings per share.</li><li>The company recorded a 9% organic revenue growth due to strong demand, coupled with a disciplined execution that contributed to a 90 basis-point expansion in EBITDA margin.</li></ul>

Xylem Inc.delivered a strong financial performance for its fourth quarter, exceeding expectations in both revenue and earnings per share.The company recorded a 9% organic revenue growth due to strong demand, coupled with a disciplined execution that contributed to a 90 basis-point expansion in EBITDA margin.

Xylem Inc: Strong Operational Performance and Future Expectations! - Major Drivers

<ul><li>Xylem, Inc. surpassed the revenue expectations as well as the earnings expectations of Wall Street.</li><li>The utility segment reported a 17% increase, propelled by strong demand and price realization in both Measurement and Control Solutions and Water Infrastructure.</li><li>Applied Water achieved a 12% revenue growth, driven by strong price realization and backlog execution.</li></ul>

Xylem, Inc. surpassed the revenue expectations as well as the earnings expectations of Wall Street.The utility segment reported a 17% increase, propelled by strong demand and price realization in both Measurement and Control Solutions and Water Infrastructure.Applied Water achieved a 12% revenue growth, driven by strong price realization and backlog execution.

Xylem Inc.: Initiation of Coverage - Business Strategy

United States

Xylem, Inc. is a designer, manufacturer, equipment and service provider for water and wastewater applications addressing the full-cycle of water from collection, distribution, and use to the return of water to the environment. The Company's products include water and wastewater pumps, treatment and testing equipment, industrial pumps, valves, heat exchangers, and dispensing equipment.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Xylem Inc (XYL US)

Xylem Inc.: How Its Recent Operational Excellence & Synergy Capture From Evoqua Integration Driving our Optimism! - Major Drivers

Xylem's Third Quarter 2024 Earnings presented a mixed financial picture marked by strong profit margins and operational discipline but moderated...

Baptista Research

Xylem Inc.: Strategic Focus On Emerging Markets & Diverse Portfolio Driving Our Bullish Thesis! - Major Drivers

Xylem's performance in the second quarter of 2024 has exceeded expectations across several key metrics. The company has demonstrated strong...

Baptista Research

Xylem Inc.: Maximizing Value Through Integration! - Major Drivers

On the optimistic front, Xylem reported a formidable first-quarter, outperforming expectations across revenue, margin, and earnings per...

Baptista Research

Xylem Inc: Strong Operational Performance and Future Expectations! - Major Drivers

Xylem Inc. delivered a strong financial performance for its fourth quarter, exceeding expectations in both revenue and earnings per share. The...

Baptista Research

Xylem Inc.: Initiation of Coverage - Business Strategy

Xylem, Inc. surpassed the revenue expectations as well as the earnings expectations of Wall Street. The utility segment reported a 17% increase,...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)